Indian Markets Show Minor Gains Amid Pharma Rally and Positive Economic Data
Indices trade with minor gains; pharma shares rally for 5th day
Business Standard
Image: Business Standard
Indian equity benchmarks saw minor gains in mid-morning trade, buoyed by optimism over a potential US-Iran peace deal and positive economic indicators. The Nifty Pharma index surged for the fifth consecutive day, reflecting strong performance from various pharmaceutical companies.
- 01S&P BSE Sensex rose by 125.32 points to 77,145.29.
- 02Nifty Pharma index increased by 1.63%, marking a 3.43% rise over five days.
- 03HSBC India Services PMI rose to 58.8, indicating strong service sector growth.
- 04Brent crude oil prices fell to $108.41 per barrel.
- 05The rupee strengthened to 95.16 against the dollar.
Advertisement
In-Article Ad
Indian equity markets experienced minor gains during mid-morning trading, with the S&P BSE Sensex adding 125.32 points to reach 77,145.29 and the Nifty 50 index increasing by 60.60 points to 24,096.40. The Nifty Pharma index notably rallied for the fifth consecutive session, rising 1.63% to 23,953.60. Key pharmaceutical stocks such as Wockhardt, Ajanta Pharma, and Alkem Laboratories contributed significantly to this surge. Positive economic indicators also emerged, with the HSBC India Services PMI Business Activity Index climbing from 57.5 in March to 58.8 in April, indicating robust growth in the service sector. Additionally, Brent crude oil prices fell to $108.41 per barrel, while the Indian rupee strengthened slightly to 95.16 against the dollar. Overall, the market breadth was strong, with more shares rising than falling, reflecting investor optimism amid easing geopolitical tensions.
Advertisement
In-Article Ad
The positive performance of the equity markets and the pharmaceutical sector indicates a recovering economy, which could lead to increased investor confidence and spending.
Advertisement
In-Article Ad
Reader Poll
Do you think the Indian pharmaceutical sector will continue to grow in the coming months?
Connecting to poll...
More about HSBC
Read the original article
Visit the source for the complete story.



